RecruitingNCT07699614

Lung Health and the Microbiome Among Adults in Botswana: the Go-hema Cohort

Determinants of Lung Health Among Batswana Adults With and Without HIV: the Go-Hema Study


Sponsor

Duke University

Enrollment

900 participants

Start Date

Dec 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Chronic respiratory diseases like chronic obstructive pulmonary disease (COPD) are responsible for millions of deaths each year, the majority of which occur in low- and middle-income countries (LMICs). LMICs also have high rates of abnormal lung function, including restrictive spirometric pattern (RSP), which can precede the development of chronic respiratory diseases and is associated with all-cause mortality. Additionally, LMICs in sub-Saharan Africa are home to the majority of the world's population of people with HIV (PWH). HIV increases the risk of COPD and COPD associated mortality, but the mechanisms underlying this risk are incompletely understood.


Eligibility

Min Age: 35 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with obstructive pulmonary disease and restrictive pulmonary disease. The study is currently recruiting participants at 1 location. People eligible for this study include aged 35 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Local Health Facilities in Gaborone

Gaborone, Botswana

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07699614


Related Trials